These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24214532)

  • 21. Susceptibility of wood ducks to H5N1 highly pathogenic avian influenza virus.
    Brown JD; Stallknecht DE; Valeika S; Swayne DE
    J Wildl Dis; 2007 Oct; 43(4):660-7. PubMed ID: 17984261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of GFP-expressing influenza viruses for the detection of influenza virus A/H5N1 neutralizing antibodies.
    Rimmelzwaan GF; Verburgh RJ; Nieuwkoop NJ; Bestebroer TM; Fouchier RA; Osterhaus AD
    Vaccine; 2011 Apr; 29(18):3424-30. PubMed ID: 21396410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental infections of herring gulls (Larus argentatus) with H5N1 highly pathogenic avian influenza viruses by intranasal inoculation of virus and ingestion of virus-infected chicken meat.
    Brown JD; Stallknecht DE; Swayne DE
    Avian Pathol; 2008 Aug; 37(4):393-7. PubMed ID: 18622855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.
    Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H
    Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
    Zhang R; Rong X; Pan W; Peng T
    Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance and characterization of low pathogenic H5 avian influenza viruses isolated from wild migratory birds in Korea.
    Baek YH; Pascua PN; Song MS; Park KJ; Kwon HI; Lee JH; Kim SY; Moon HJ; Kim CJ; Choi YK
    Virus Res; 2010 Jun; 150(1-2):119-28. PubMed ID: 20227447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avian influenza A (H5N1) virus antibodies in pigs and residents of swine farms, southern China.
    Cao N; Zhu W; Chen Y; Tan L; Zhou P; Cao Z; Ke C; Li Y; Wu J; Qi W; Jiao P; Zhang G
    J Clin Virol; 2013 Dec; 58(4):647-51. PubMed ID: 24231290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong.
    Shortridge KF; Zhou NN; Guan Y; Gao P; Ito T; Kawaoka Y; Kodihalli S; Krauss S; Markwell D; Murti KG; Norwood M; Senne D; Sims L; Takada A; Webster RG
    Virology; 1998 Dec; 252(2):331-42. PubMed ID: 9878612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
    Jiang Y; Yu K; Zhang H; Zhang P; Li C; Tian G; Li Y; Wang X; Ge J; Bu Z; Chen H
    Antiviral Res; 2007 Sep; 75(3):234-41. PubMed ID: 17451817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.
    Pitaksajjakul P; Lekcharoensuk P; Upragarin N; Barbas CF; Ibrahim MS; Ikuta K; Ramasoota P
    Biochem Biophys Res Commun; 2010 May; 395(4):496-501. PubMed ID: 20382115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microparticle and anti-influenza activity in human respiratory secretion.
    Suptawiwat O; Ruangrung K; Boonarkart C; Puthavathana P; Maneechotesuwan K; Charngkaew K; Chomanee N; Auewarakul P
    PLoS One; 2017; 12(8):e0183717. PubMed ID: 28832645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. INVESTIGATIONS OF SOME EFFECTS OF HUMAN SALIVA ON INFLUENZA VIRUS.1. HAEMAGGLUTINATION INHIBITION AND NEUTRALIZATION.
    ROELLA G
    Acta Pathol Microbiol Scand; 1965; 63():291-8. PubMed ID: 14301676
    [No Abstract]   [Full Text] [Related]  

  • 34. Hydrogen peroxide inactivation of influenza virus preserves antigenic structure and immunogenicity.
    Dembinski JL; Hungnes O; Hauge AG; Kristoffersen AC; Haneberg B; Mjaaland S
    J Virol Methods; 2014 Oct; 207():232-7. PubMed ID: 25025814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza virus and its mucoprotein substrate in the chorioallantoic membrane of the chick embryo. I. Characterization and quantitative assay of soluble substrate and studies on its relation to allantoic cells.
    SCHLESINGER RW; KARR HV
    J Exp Med; 1956 Mar; 103(3):309-32. PubMed ID: 13295489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avian influenza virus infection risk in humans with chronic diseases.
    Zhong Y; Qin Y; Yu H; Yu J; Wu H; Chen L; Zhang P; Wang X; Jia Z; Guo Y; Zhang H; Shan J; Wang Y; Xie H; Li X; Li Z
    Sci Rep; 2015 Mar; 5():8971. PubMed ID: 25754427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoenzymatic synthesis and characterization of N-glycolylneuraminic acid-carrying sialoglycopolypeptides as effective inhibitors against equine influenza virus hemagglutination.
    Ogata M; Koizumi A; Otsubo T; Ikeda K; Sakamoto M; Aita R; Kato T; Park EY; Yamanaka T; Hidari KIPJ
    Biosci Biotechnol Biochem; 2017 Aug; 81(8):1520-1528. PubMed ID: 28521605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition.
    Mammen M; Dahmann G; Whitesides GM
    J Med Chem; 1995 Oct; 38(21):4179-90. PubMed ID: 7473545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sialidase and protease activities of commercial (RDE) receptor destroying enzyme products used for the (HI) hemagglutination inhibition test of influenza viruses.
    Nakayama M; Ogawa Y; Yamazi Y
    Nihon Ika Daigaku Zasshi; 1986 Oct; 53(5):534-6. PubMed ID: 3536992
    [No Abstract]   [Full Text] [Related]  

  • 40. Rat alpha 1 macroglobulin inhibits hemagglutination by influenza C virus.
    Herrler G; Geyer R; Müller HP; Stirm S; Klenk HD
    Virus Res; 1985 Mar; 2(2):183-92. PubMed ID: 2581392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.